Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-thrombotic Monotherapy Transition in HeartMate 3 LVAS Patients
NCT03781258Unknown
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Nov 2018
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of aspirin in heart failure (HF), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoint: Survival free of a pump malfunction due to thrombosis or any ischemic stroke at 180 days. Status: unknown.
02
Drugs
aspirin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03781258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781258.